Scioto Biosciences Invested 2018

Scioto Biosciences is a preclinical stage company developing innovative therapies devoted to having a transformative impact on the delivery of microbiome therapeutics. The Scioto Platform is a novel formulation that primes the colony-forming mechanisms of live bacteria therapeutics by combining beneficial bacteria with polysaccharide microspheres. These natural mechanisms induce biofilm formation, enhance function and allow for non-spore forming bacteria to survive passage through the gastrointestinal system. The platform has the potential to enhance efficacy wherever live bacterial therapeutics are used such as diabetes, neurological disorders, gastrointestinal health, alternatives to in-feed antibiotics for livestock, and others.

Looking for Funding?

VisionTech Partners may be able to help. Through VisionTech Angels and a broad network of investors and business resources, our goal is to help promising ventures succeed. We focus on early stage and early growth technology-based companies in Indiana and the Midwest.

If you have questions or would like more information, Contact Us. If you’re ready to start the process, Submit Your Business Plan using the secure website of Gust, the global platform for angel investing. We look forward to hearing from you!